EndoSound’s Vision System, a platform whose transducer transforms a conventional upper endoscope into a fully functional endoscopic ultrasound device, received FDA breakthrough device designation in July 2021, according to a Jan. 24 news release from the company. The platform has not been cleared by the FDA.
EndoSound will use the funding to improve Vision System’s access, reduce cost and increase safety, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
